Vaccinogen's Series A Round

Vaccinogen raised a round of funding on December 22, 2008.

Vaccinogen is a cancer vaccine company developing OncoVAX as a treatment to prevent the recurrence of colon cancer and potentially other solid tumors. Vaccinogen has developed and patented a process t…

Articles about Vaccinogen's Series A Round: